Продължаващо медицинско обучение по онкология и онкохематология

Научноизследователски ресурси

Научни публикации

PerspectiveHealthcare (MDPI) 2026, 14(18), 2973Публикувана на 11.09.2026

Preventable, Yet Unprevented: The Cervical Cancer Screening Landscape in Eastern Europe and Bulgaria

Angel Yordanov, Tsvetan Yordanov, Eva Tsoneva, Ivaylo Petrov, Ihsan Hasan, Dimo Manov, Stoyan Kostov and Assia Konsoulova

  • cervical cancer
  • HPV screening
  • Balkans
  • Eastern Europe
  • Bulgaria
  • dual staining
  • p16/Ki-67
  • liquid-based cytology
  • cancer prevention
Резюме (на английски език)

Cervical cancer is one of the most preventable malignancies, yet disparities in survival remain a significant public health burden across Eastern Europe and the Balkans. Bulgaria illustrates this paradox: HPV vaccination coverage is very low, and prevention continues to rely substantially on opportunistic screening, although recent national initiatives have introduced HPV-based testing and self-sampling. This article argues that the primary barrier to cervical cancer control in Bulgaria is not the lack of medical technology, but the absence of a structured, organized screening system. A modern national cervical cancer screening program should be recognized as a structured clinical and organizational pathway rather than a single diagnostic test. Such a programme requires population identification, active invitation and recall, reg-istry-based tracking, standardized referral and follow-up pathways, and continuous quality assurance. Primary high-risk HPV (hrHPV) testing provides high sensitivity and excellent negative predictive value, supporting longer screening intervals; however, screening for HPV positivity alone is insufficient as a sole referral criterion because many infections are transient and clinically insignificant. We propose a rational framework for cervical cancer screening in Bulgaria and comparable health systems: invitation-based screening for women aged 25–65 years built on primary hrHPV testing with genotyping, reflex cytology, and selective use of p16/Ki-67 dual staining. Drawing on a regional comparison of HPV vaccination and screening programs and on Bulgarian cost-of-illness data, we argue that transitioning from opportunistic testing to an integrated, registry-based screening cascade is essential for effective and equitable cervical cancer prevention in the region.

PolicyOBS-PACE (European Observatory on Health Systems and Policies)Публикувана на 11.05.2026

National screening programs for cervical cancer and colorectal cancer, 2025–2030, Bulgaria

Ivaylo Petrov, Assia Konsoulova, Angel Yordanov, Divya Ramroop and Yulia Litvinova

  • Prevention
  • Implementation paused
  • National
  • Bulgaria
Резюме (на английски език)

In 2025, Ministry of Health in Bulgaria introduced national population-based screening programs for cervical and colorectal cancers, linking these initiatives to the National Cancer Control Plan and National Health Strategy 2030, with an announced ambition to reach more than 4 million people through organized HPV and FIT-based testing (BurgasMedia, 2025). The policy aimed to shift Bulgaria away from weak and fragmented opportunistic screening toward a more structured model with invitation, follow-up diagnostics and registry-linked monitoring. However, by early 2026, implementation of the screening programs had been paused and placed under review following concerns about procurement, pricing, transparency, operational readiness and governance. As a result, the policy remains active as an objective but not operational in practice, with its status now better understood as a screening reform under revision rather than a completed national rollout.